Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Jan 14, 2021
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
General Notices
- Notice of NIH Participation in the National Science Foundation Enabling Discovery through GEnomics (EDGE) Program
National Human Genome Research Institute - NHGRI Notice of Participation in PAR-19-134, "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)"
National Human Genome Research Institute - AHRQ Notice of Extension of PA-17-007
Agency for Healthcare Research and Quality - Findings of Research Misconduct
National Institutes of Health - Request for Information (RFI): Inviting Comments and Suggestions on the Surgeon-Scientist effort requirement on K08 awards from the National Cancer Institute
National Cancer Institute
Notice of Changes to Funding Opportunities
- Notice to Extend the Expiration Date for PAR-18-580 "Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (UT2 Clinical Trial Optional)"
National Institute on Alcohol Abuse and Alcoholism - Notice to Update Data Sharing Plan in Section I - Funding Opportunity Description for RFA-FD-21-013 - "Physiologically-based pharmacokinetic (PBPK) models to aid the development of generic dermatological products (U01) Clinical Trials Optional."
Food and Drug Administration - Notice to Update Data Sharing Plan in Section I - Development of Methods to Evaluate the Impact of Design Differences to the User Interface of Generic Drug-Device Combination Products in Comparison to their Reference Listed Drugs
Food and Drug Administration - Clarification of Scientific Overlap Concerns in PAR-19-367 "Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)"
National Institute of General Medical Sciences - Notice of NIMHD Participation in the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) Program
National Institute on Minority Health and Health Disparities - Notice of NIMHD Participation in PA-21-049 and PA-21-050, Announcements for Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowships for Students in Predoctoral Dual-Degree Training Programs (Parent F30)
National Institute on Minority Health and Health Disparities - Notice to Extend Expiration Date for PAR-19-362: Planning Grant for Global Infectious Disease Research Training Program (D71 - Clinical Trials Not Allowed)
John E. Fogarty International Center
Notices of Special Interest
- Notice of Special Interest: Alcohol-induced Tissue-specific and Organ System Diseases (R01/R21/R03)
National Institute on Alcohol Abuse and Alcoholism - Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases - Notice of Special Interest (NOSI): Leveraging Population-based Cancer Registry Data to Study Health Disparities
National Cancer Institute - Notice of Special Interest (NOSI): Innovative Molecular Analysis Technologies for Low-Resource Settings Globally
National Cancer Institute
Funding Opportunities
- International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed
- International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required)
John E. Fogarty International Center
National Cancer Institute
- Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
National Center for Advancing Translational Sciences
- Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases
- Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed)
National Institute on Aging
- New Approaches to Identify Neurogenesis and Study its Dynamics in Brain Aging and AD/ADRD (R01 Clinical Trial Not Allowed)
National Institute on Aging
- Pilot and Feasibility Studies to Facilitate the Use of Diabetes Self-Management Education and Support to Improve Diabetes Care (R34 Clinical Trial Required)
National Institute of Diabetes and Digestive and Kidney Diseases
- Physiologically Based Pharmacokinetic (PBPK) Models of Oral Absorption to Simulate the Results of Bioequivalence Studies (U01) Clinical Trials Optional
Food and Drug Administration
- Computational Fluid Dynamics (CFD) Models to Aid the Development of Generic Inhalation Products (U01) Clinical Trials Optional
Food and Drug Administration
- Development of Advanced Analytical Methods for the Characterization of Iron Carbohydrate Complex - Ferric Derisomaltose (U01) Clinical Trials Not Allowed
Food and Drug Administration
- Quantify the expression of metabolizing enzymes and transporter proteins in lung, eye and skin tissue in relevant animal models and humans (U01) Clinical Trial Not Allowed
Food and Drug Administration
- National Food and Nutrient Analysis Program (U01) Clinical Trial Not Applicable
Food and Drug Administration
- Development of a model selection method for population pharmacokinetics analysis by deep-learning based reinforcement learning (U01) Clinical Trials Not Allowed
Food and Drug Administration
- Understanding and Reducing Cardiovascular Disease in Type 1 Diabetes Mellitus (R01 Clinical Trial Optional)
National Heart, Lung, and Blood Institute
National Institute of Diabetes and Digestive and Kidney Diseases
- Next Generation Sequencing in Post Mortem Tissue from Patients with Parkinsons Disease (U01 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
- Cellular Senescence Network: Tissue Mapping Centers (U54 Clinical Trial Not Allowed)
- Cellular Senescence Network: Technology Development and Application (UG3/UH3 Clinical Trial Not Allowed)
- Cellular Senescence Network: Consortium Organization and Data Coordinating Center (U24 Clinical Trial Not Allowed)
Office of Strategic Coordination (Common Fund)
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu